Fat loss results vary and depend on nutrition, activity, sleep, hormones, labs, and medical guidance
Elevated levels of ROS and oxidative damage markers, such as 8-OHdG and MDA, have been detected in the synovial fluid and tissues of RA patients
The emerging availability of therapies capable of augmenting RBC ATP, including newly established uses of allosteric effectors and metabolite-specific additive solutions for RBC transfusates, raises the prospect of clinical interventions to optimize or correct RBC function via these metabolite delivery mechanisms
Studies indicate that it affects neurotransmitters such as serotonin, dopamine, and norepinephrine, all of which play a role in supporting sleep, promoting mood enhancement, and reducing stress
acting on receptors throughout the body and governing tissue integrity, bone metabolism, neurological health, vascular function, and fat utilization